drugset / Trial / NCT02340130

Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma

NCT02340130 ↗

Phase 2 Completed 57 enrolled Laboratorios Leti, S.L.
RandomizedSingle-groupOpen-labelTreatment

Summary

This is an open-label, non-controlled, non-randomised, prospective safety study in patients with rhinitis or allergic rhinoconjunctivitis, with controlled asthma, and clinically relevant sensitisation to dust mites from the Pyroglyphidae and Glycyphagidae families.

Timeline

Start
2014-09
Primary completion
2018-05
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject DP/MG/14-1 Unknown — —
Subject DP/MG/14-2 Unknown — —